Literature DB >> 6585834

Mechanism of the inhibition of the gamma-carboxylation of glutamic acid by N-methylthiotetrazole-containing antibiotics.

J J Lipsky.   

Abstract

Antibiotics that contain a 1-N-methyl-5-thiotetrazole (MTT) side group have been associated with hypoprothrombinemia. In a detergent-treated rat liver microsomal system, MTT inhibited the carboxylation of the gamma carbon of glutamic acid, a necessary reaction in the synthesis of four of the clotting factors. In the present work, the inhibition by MTT was found to be slow in onset, with a lag time of 15 min before significant inhibition occurred. A preincubation of MTT with the microsomes decreased the lag time and increased the extent of inhibition. Glutathione at 1 mM was found to markedly decrease the ability of MTT to inhibit this reaction. The disulfide dimer of MTT was a more potent inhibitor of the system than was MTT, with inhibition detected as low as 1 microM dimer. Disulfiram also inhibited the carboxylation system. These results indicate that the sulfhydryl group of MTT is important for the inhibitory effect of MTT and suggest that a slowly formed metabolite of MTT may be directly responsible for the observed inhibition. The inhibitory mechanism of MTT may be analogous to that of disulfiram, which would explain some pharmacologic effects in common with disulfiram. In addition, the in vitro observations presented here and a closer examination of the clinical evidence raise the possibility that MTT-containing antibiotic-induced hypoprothrombinemia may not be a vitamin K reversible phenomenon.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6585834      PMCID: PMC345179          DOI: 10.1073/pnas.81.9.2893

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  22 in total

1.  Soluble enzyme system for vitamin K-dependent carboxylation.

Authors:  D O Mack; E T Suen; J M Girardot; J A Miller; R Delaney; B C Johnson
Journal:  J Biol Chem       Date:  1976-06-10       Impact factor: 5.157

2.  Dose response and minimal daily requirement for vitamin K in man.

Authors:  P G Frick; G Riedler; H Brögli
Journal:  J Appl Physiol       Date:  1967-09       Impact factor: 3.531

3.  Vitamin K in hereditary resistance to oral anticoagulant drugs.

Authors:  R A O'Reilly
Journal:  Am J Physiol       Date:  1971-11

4.  Gastrointestinal bleeding due to vitamin K deficiency in patients on parenteral cefamandole.

Authors:  C A Hooper; B B Haney; H H Stone
Journal:  Lancet       Date:  1980-01-05       Impact factor: 79.321

5.  Partial sequence of rat prothrombin and the activity of two related pentapeptides as substrates for the vitamin K-dependent carboxylase system.

Authors:  R M Houser; D J Carey; K M Dus; G R Marshall; R E Olson
Journal:  FEBS Lett       Date:  1977-03-15       Impact factor: 4.124

6.  Interaction of sodium warfarin and disulfiram (antabuse) in man.

Authors:  R A O'Reilly
Journal:  Ann Intern Med       Date:  1973-01       Impact factor: 25.391

7.  Electronic structures of cephalosporins and penicillins. 9. Departure of a leaving group in cephalosporins.

Authors:  D B Boyd; W H Lunn
Journal:  J Med Chem       Date:  1979-07       Impact factor: 7.446

Review 8.  Studies on the absorption and metabolism of phylloquinone (vitamin K1) in man.

Authors:  M J Shearer; A McBurney; P Barkhan
Journal:  Vitam Horm       Date:  1974       Impact factor: 3.421

9.  Vitamin K deficiency developing in patients with renal failure treated with cephalosporin antibiotics.

Authors:  J Reddy; R R Bailey
Journal:  N Z Med J       Date:  1980-11-26

Review 10.  Mechanism of action of vitamin K: synthesis of gamma-carboxyglutamic acid.

Authors:  J W Suttie
Journal:  CRC Crit Rev Biochem       Date:  1980
View more
  15 in total

1.  Effects of N-methyl-thiotetrazole cephalosporin on haemostasis in patients with reduced serum vitamin K1 concentrations.

Authors:  I J Mackie; K Walshe; H Cohen; P McCarthy; M Shearer; S D Scott; S J Karran; S J Machin
Journal:  J Clin Pathol       Date:  1986-11       Impact factor: 3.411

2.  Pharmacokinetic properties of the newer cephalosporins. A valid basis for drug selection?

Authors:  J T Noble; M Barza
Journal:  Drugs       Date:  1985-09       Impact factor: 9.546

3.  Comparative effects of cefoxitin and cefotetan on vitamin K metabolism.

Authors:  R R Sieradzan; W A Bottner; M J Fasco; J S Bertino
Journal:  Antimicrob Agents Chemother       Date:  1988-09       Impact factor: 5.191

4.  Comparative evaluation of the pharmacokinetics of N-methylthiotetrazole following administration of cefoperazone, cefotetan, and cefmetazole.

Authors:  L S Welage; M T Borin; J H Wilton; L G Hejmanowski; P B Wels; J J Schentag
Journal:  Antimicrob Agents Chemother       Date:  1990-12       Impact factor: 5.191

5.  Role of prophylactic vitamin K in preventing antibiotic induced hypoprothrombinemia.

Authors:  Farookh Aziz; Prashant Patil
Journal:  Indian J Pediatr       Date:  2014-10-10       Impact factor: 1.967

Review 6.  Antibacterial therapy in patients with malignancies.

Authors:  K H Mayer; S M Opal
Journal:  Cancer Metastasis Rev       Date:  1987       Impact factor: 9.264

7.  The comparative influence of prophylactic antibiotics on the prothrombin response to warfarin in the postoperative prosthetic cardiac valve patient. Cefamandole, cefazolin, vancomycin.

Authors:  D M Angaran; V C Dias; K V Arom; W F Northrup; T G Kersten; W G Lindsay; D M Nicoloff
Journal:  Ann Surg       Date:  1987-08       Impact factor: 12.969

8.  Effects of cefonicid and other cephalosporin antibiotics on male sexual development in rats.

Authors:  J M Manson; L E Zolna; Y J Kang; C M Johnson
Journal:  Antimicrob Agents Chemother       Date:  1987-07       Impact factor: 5.191

9.  Antibiotic treatment and associated prolonged prothrombin time.

Authors:  K J Williams; R P Bax; H Brown; S J Machin
Journal:  J Clin Pathol       Date:  1991-09       Impact factor: 3.411

10.  Comparison of N-methylthiotetrazole dispositions in healthy volunteers following single intravenous doses of moxalactam, cefoperazone, and cefotetan.

Authors:  L S Welage; L G Hejmanowski; J H Wilton; C Walawander; D Rigan; J S Williams; J J Schentag
Journal:  Antimicrob Agents Chemother       Date:  1989-06       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.